The 7th Edition Cancer Staging Manual incorporates significant changes in cancer staging for specific disease sites. The purpose of this presentation is to highlight the major changes in the 7th edition and review the new and emerging prognostic factors related to cancer staging. As standards of care have evolved through the years, the staging rules have been modified to reflect these changes. The relationship between AJCC staging and the Collaborative Staging version 2 will be explored, leading to an understanding of the data elements recorded by the cancer registrar.
Target Audience: This program is intended for physicians and registrars.
1. Review the modifications to the staging rules
2. Identify the changes to the key sites
3. Detect the role of the prognostic factors
4. Examine the relationship between AJCC and CSv2
Financial support for the development of this presentation and webinar has been provided by the American Cancer Society. The information provided here does not necessarily represent the views of the American Cancer Society, Society Staff, or it's Board of Directors.
For registration support, please call 1-800-274-9390 or email firstname.lastname@example.org
If you would like to pay by check or register via telephone, please contact our Customer Support Group at 1-800-274-9390.
David R. Byrd, MD, FACS
University of Washington
David R. Byrd, MD, FACS is a Professor of Surgery and the director of the Melanoma Center at the University of Washington. Dr. Byrd is also the Vice Chair of the American Joint Committee on Cancer and an editor of the 7th edition Cancer Staging Manual. Dr. Byrd is the founder and Attending Surgeon Harborview Medical Center Breast Clinic Seattle, Washington. He was the first surgeon to bring the sentinel lymph node biopsy technique to the Northwest. He is an expert in many surgical procedures, including the Whipple procedure used in pancreas cancer treatment. His clinical interests include Surgical oncology; thyroid, parathyroid, and adrenal neoplasms; gastrointestinal cancers, pancreatic cancer, melanoma, breast cancer, sarcoma. Dr. Byrd's research interests are molecular changes in pancreatic cancer; genetic and clinical studies on melanoma; lymphatic mapping in breast cancer and melanoma.
Continuing Medical Education Credit: All content of this webinar is the legal property of the American College of Surgeons. Continuing Medical Education (CME) is NOT available for this program nor can anyone assign CME credit to this activity which is the property of the American College of Surgeons. Any assignment of CME credit would be in violation of ACCME regulations.